Theravance Biopharma, Inc. (TBPH)
17.34
-0.47
(-2.64%)
USD |
NASDAQ |
Dec 10, 13:41
Theravance Biopharma Market Cap: 878.66M for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Perspective Therapeutics, Inc. | 189.93M |
| Skye Bioscience, Inc. | 37.19M |
| FibroGen, Inc. | 34.76M |
| Myomo, Inc. | 39.97M |
| VYNE Therapeutics, Inc. | 13.65M |
Market Cap Related Metrics
| PE Ratio | 30.83 |
| PS Ratio | 10.88 |
| Price to Book Value | 3.776 |
| Price to Free Cash Flow | 3.590 |
| Price | 17.34 |
| Earnings Yield | 3.24% |
| Normalized PE Ratio | 30.83 |